InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,778.93
(
-0.23%
)
US TECH 100
19,656.40
(
-0.35%
)
Dow Jones
42,430.56
(
-0.19%
)
Brent Oil
78.40
(
2.30%
)
Bitcoin
60,765.31
(
0.31%
)
Post# of 253330
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120555
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: flatlander_60048 post# 88968

Thursday, 01/21/2010 11:35:26 PM

Thursday, January 21, 2010 11:35:26 PM

Post# of 253330
Japan approves NVS’ Galvus, which goes by the brand name Equa there:

http://finance.yahoo.com/news/Novartis-says-3-drugs-apf-2846517563.html?x=0&.v=1

That leaves the US as the only major market where Galvus is not—and probably never will be—approved.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up